Targeting the spliceosome through RBM39 degradation results in exceptional responses in high-risk neuroblastoma models.
Shivendra SinghWaise QuarniMaria GoralskiShibiao WanHongjian JinLee-Ann Van de VeldeJie FangQiong WuAhmed Abu-ZaidTingting WangRavi SinghDavid CraftYiping FanThomas ConferMelissa JohnsonWalter J AkersRuoning WangPeter J MurrayPaul Glyndwr ThomasDeepak NijhawanAndrew M DavidoffJun J YangPublished in: Science advances (2021)
[Figure: see text].